160 related articles for article (PubMed ID: 38805342)
1. Challenges in the treatment of dysthymia: a narrative review.
Mathias L; Quagliato LA; Carta MG; Nardi AE; Cheniaux E
Expert Rev Neurother; 2024 Jul; 24(7):633-642. PubMed ID: 38805342
[TBL] [Abstract][Full Text] [Related]
2. The undertreatment of dysthymia.
Shelton RC; Davidson J; Yonkers KA; Koran L; Thase ME; Pearlstein T; Halbreich U
J Clin Psychiatry; 1997 Feb; 58(2):59-65. PubMed ID: 9062374
[TBL] [Abstract][Full Text] [Related]
3. Moclobemide and imipramine in chronic depression (dysthymia): an international double-blind, placebo-controlled trial. International Collaborative Study Group.
Versiani M; Amrein R; Stabl M
Int Clin Psychopharmacol; 1997 Jul; 12(4):183-93. PubMed ID: 9347378
[TBL] [Abstract][Full Text] [Related]
4. Treatment of dysthymia and minor depression in primary care: a randomized trial in patients aged 18 to 59 years.
Barrett JE; Williams JW; Oxman TE; Frank E; Katon W; Sullivan M; Hegel MT; Cornell JE; Sengupta AS
J Fam Pract; 2001 May; 50(5):405-12. PubMed ID: 11350703
[TBL] [Abstract][Full Text] [Related]
5. Second-generation antipsychotics for major depressive disorder and dysthymia.
Komossa K; Depping AM; Gaudchau A; Kissling W; Leucht S
Cochrane Database Syst Rev; 2010 Dec; (12):CD008121. PubMed ID: 21154393
[TBL] [Abstract][Full Text] [Related]
6. Treatment of dysthymia and minor depression in primary care: A randomized controlled trial in older adults.
Williams JW; Barrett J; Oxman T; Frank E; Katon W; Sullivan M; Cornell J; Sengupta A
JAMA; 2000 Sep; 284(12):1519-26. PubMed ID: 11000645
[TBL] [Abstract][Full Text] [Related]
7. Review of dysthymia and persistent depressive disorder: history, correlates, and clinical implications.
Schramm E; Klein DN; Elsaesser M; Furukawa TA; Domschke K
Lancet Psychiatry; 2020 Sep; 7(9):801-812. PubMed ID: 32828168
[TBL] [Abstract][Full Text] [Related]
8. Pharmacotherapy of dysthymic and chronic depressive disorders: overview with focus on moclobemide.
Versiani M
J Affect Disord; 1998 Dec; 51(3):323-32. PubMed ID: 10333986
[TBL] [Abstract][Full Text] [Related]
9. Current pharmacotherapeutic approaches for dysthymic disorder and persistent depressive disorder.
Carta MG; Paribello P; Nardi AE; Preti A
Expert Opin Pharmacother; 2019 Oct; 20(14):1743-1754. PubMed ID: 31290333
[No Abstract] [Full Text] [Related]
10. The long-term outcome of dysthymia in private practice: clinical features, temperament, and the art of management.
Haykal RF; Akiskal HS
J Clin Psychiatry; 1999 Aug; 60(8):508-18. PubMed ID: 10485632
[TBL] [Abstract][Full Text] [Related]
11. Comparative effectiveness of continuation and maintenance treatments for persistent depressive disorder in adults.
Machmutow K; Meister R; Jansen A; Kriston L; Watzke B; Härter MC; Liebherz S
Cochrane Database Syst Rev; 2019 May; 5(5):CD012855. PubMed ID: 31106850
[TBL] [Abstract][Full Text] [Related]
12. A comparison of drugs versus placebo for the treatment of dysthymia.
Lima MS; Moncrieff J
Cochrane Database Syst Rev; 2000; (2):CD001130. PubMed ID: 10796749
[TBL] [Abstract][Full Text] [Related]
13. Drugs versus placebo for dysthymia.
Lima MS; Moncrieff J
Cochrane Database Syst Rev; 2000; (4):CD001130. PubMed ID: 11034701
[TBL] [Abstract][Full Text] [Related]
14. Double-blind comparison of sertraline, imipramine, and placebo in the treatment of dysthymia: psychosocial outcomes.
Kocsis JH; Zisook S; Davidson J; Shelton R; Yonkers K; Hellerstein DJ; Rosenbaum J; Halbreich U
Am J Psychiatry; 1997 Mar; 154(3):390-5. PubMed ID: 9054788
[TBL] [Abstract][Full Text] [Related]
15. Treatments for later-life depressive conditions: a meta-analytic comparison of pharmacotherapy and psychotherapy.
Pinquart M; Duberstein PR; Lyness JM
Am J Psychiatry; 2006 Sep; 163(9):1493-501. PubMed ID: 16946172
[TBL] [Abstract][Full Text] [Related]
16. Antidepressant efficacy in the treatment of dysthymia.
Invernizzi G; Mauri MC; Waintraub L
Eur Neuropsychopharmacol; 1997 Oct; 7 Suppl 3():S329-36. PubMed ID: 9405959
[TBL] [Abstract][Full Text] [Related]
17. Dopaminergic deficit and the role of amisulpride in the treatment of mood disorders.
Montgomery SA
Int Clin Psychopharmacol; 2002 Dec; 17 Suppl 4():S9-15; discussion S16-7. PubMed ID: 12685917
[TBL] [Abstract][Full Text] [Related]
18. A meta-analysis of psychotherapy and medication in unipolar depression and dysthymia.
Imel ZE; Malterer MB; McKay KM; Wampold BE
J Affect Disord; 2008 Oct; 110(3):197-206. PubMed ID: 18456340
[TBL] [Abstract][Full Text] [Related]
19. Treatment of double depression: A meta-analysis.
May DG; Shaffer VN; Yoon KL
Psychiatry Res; 2020 Sep; 291():113262. PubMed ID: 32763535
[TBL] [Abstract][Full Text] [Related]
20. Treatment of primary dysthymia with group cognitive therapy and pharmacotherapy: clinical symptoms and functional impairments.
Ravindran AV; Anisman H; Merali Z; Charbonneau Y; Telner J; Bialik RJ; Wiens A; Ellis J; Griffiths J
Am J Psychiatry; 1999 Oct; 156(10):1608-17. PubMed ID: 10518174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
